NEW YORK (GenomeWeb News) – PerkinElmer today announced a collaboration with researchers at Massachusetts General Hospital for the development of a sequencing informatics system to profile genetic changes in tumors.
PerkinElmer will work with John Iafrate and Long Le of the hospital's pathology department and cancer center to develop the system, which will be based on PerkinElmer's Geospiza platforms to allow for genotype analysis to define key targets.
PerkinElmer will develop a highly automated sample preparation and data analysis system that can be used for cancer genotyping in cancer research at the hospital's pathology department and cancer center. Its Geospiza GeneSifter Laboratory and Analysis edition software platform will be "enhanced with sophisticated variant detection algorithms," the company said, and the new system will have enhanced LIMS and data analysis capabilities integrated into existing laboratory processes and equipment to support Iafrate's and Le's research.
The hospital's pathology lab and cancer center currently uses services and data from PerkinElmer's DNA Sequencing Services group, as well as the Waltham, Mass.-based firm's Sciclone automated liquid handling platform and the NGS Express Workstation for benchtop sequencers.
Financial and other terms of the deal were not disclosed.